BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$2.4B |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.5B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.43B |
| 4 |
Zoom
ZM
|
+$1.28B |
| 5 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.5B |
| 2 |
PPLI
People Inc
PPLI
|
+$1.26B |
| 3 |
Microsoft
MSFT
|
+$1.21B |
| 4 |
Amazon
AMZN
|
+$810M |
| 5 |
Meta Platforms (Facebook)
META
|
+$754M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.54% |
| 2 | Healthcare | 14.42% |
| 3 | Consumer Discretionary | 11.93% |
| 4 | Financials | 11.59% |
| 5 | Communication Services | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Evolus
EOLS
$530M
| $6.93M | ﹤0.01% |
1,772,143
-221,744
| -11% | -$810K |
|
|
ATXS
3402
DELISTED
Astria Therapeutics
ATXS
| $6.9M | ﹤0.01% |
185,895
+1,209
| +0.7% | +$47.9K |
|
3403
Parke Bancorp
PKBK
$413M
| $6.9M | ﹤0.01% |
578,248
-14,892
| -3% | -$186K |
|
3404
Tiptree Inc
TIPT
$677M
| $6.89M | ﹤0.01% |
1,392,492
-18,682
| -1% | -$101K |
|
3405
Enliven Therapeutics
ELVN
$4.25B
| $6.89M | ﹤0.01% |
84,698
-1,039
| -1% | -$93.7K |
|
|
NBSE
3406
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $6.88M | ﹤0.01% |
45,315
-1,318
| -3% | -$215K |
|
3407
Quantum Corp
QMCO
$973M
| $6.88M | ﹤0.01% |
74,732
-1,229
| -2% | -$120K |
|
3408
Cabaletta Bio
CABA
$442M
| $6.86M | ﹤0.01% |
632,397
+9,714
| +2% | +$112K |
|
3409
Quad
QUAD
$506M
| $6.83M | ﹤0.01% |
2,253,754
-166,386
| -7% | -$551K |
|
|
PTR
3410
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $6.82M | ﹤0.01% |
231,762
-63,999
| -22% | -$2.19M |
|
|
NESR
3411
National Energy Services Reunited Corp
NESR
$3.62B
| $6.82M | ﹤0.01% |
1,068,722
-5,876
| -0.5% | -$41.6K |
|
|
SLNO
3412
DELISTED
Soleno Therapeutics
SLNO
| $6.76M | ﹤0.01% |
179,688
+76,676
| +74% | +$2.24M |
|
3413
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $6.74M | ﹤0.01% |
108,552
+108,088
| +23,295% | +$6.72M |
|
|
PFHD
3414
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $6.74M | ﹤0.01% |
502,512
+274,407
| +120% | +$3.44M |
|
|
ARA
3415
DELISTED
American Renal Associates Holdings, Inc
ARA
| $6.73M | ﹤0.01% |
975,293
-17,778
| -2% | -$117K |
|
|
PFSW
3416
DELISTED
PFSweb, Inc.
PFSW
| $6.73M | ﹤0.01% |
1,005,519
-13,265
| -1% | -$98.4K |
|
|
FLNT
3417
Fluent
FLNT
$132M
| $6.71M | ﹤0.01% |
451,240
-28
| -0% | -$406 |
|
3418
INNOVATE Corp
VATE
$102M
| $6.69M | ﹤0.01% |
276,620
-17,003
| -6% | -$459K |
|
3419
Galectin Therapeutics
GALT
$356M
| $6.68M | ﹤0.01% |
2,503,111
-11,271
| -0.4% | -$31.6K |
|
3420
Minerva Neurosciences
NERV
$187M
| $6.68M | ﹤0.01% |
262,598
-13,792
| -5% | -$373K |
|
3421
X4 Pharmaceuticals
XFOR
$425M
| $6.68M | ﹤0.01% |
32,873
+438
| +1% | +$105K |
|
3422
Intrepid Potash
IPI
$484M
| $6.67M | ﹤0.01% |
790,396
+7,459
| +1% | +$70.9K |
|
|
RESN
3423
DELISTED
Resonant Inc.
RESN
| $6.63M | ﹤0.01% |
2,786,391
-129,661
| -4% | -$323K |
|
|
FNHC
3424
DELISTED
FedNat Holding Company Common Stock
FNHC
| $6.63M | ﹤0.01% |
1,048,442
-8,998
| -0.9% | -$81.5K |
|
3425
Richmond Mutual Bancorp
RMBI
$256M
| $6.59M | ﹤0.01% |
622,603
-59,923
| -9% | -$671K |
|
Similar funds
BlackRock's Q3 2020 Portfolio in Review
As of Q3 2020, BlackRock held 5,280 positions worth $2.71T, up 8.2% from $2.51T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2020 filing shows 239 new, 1,746 increased, 2,572 reduced and 207 closed positions. Its largest new stake was Dun & Bradstreet: 31,290,496 shares worth $803M. The largest sale was Apple, an estimated $3.5B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- BlackRock's largest Q3 2020 buy was Dun & Bradstreet: 31,290,496 shares worth $803M.
- BlackRock added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2020, an estimated $2.4B increase.
- BlackRock's biggest Q3 2020 reduction was Apple, cutting an estimated $3.5B.
- BlackRock fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $633M.
- BlackRock's ten largest holdings make up 19% of its $2.71T portfolio in Q3 2020.
- BlackRock opened 239 new positions and closed 207 in Q3 2020.
- BlackRock's portfolio value rose 8.2% quarter-over-quarter to $2.71T.
Based on BlackRock's 13F filing for Q3 2020, filed 6 Nov 2020.